Instadiagnostics
Instadiagnostics: Bringing rapid, quantitative, bedside diagnostic testing to patients.
Founded
2015Instadiagnostics: Bringing rapid, quantitative, bedside diagnostic testing to patients.
Instadiagnostics, founded with the mission to revolutionize point-of-care diagnostics, aims to bring centralized laboratory testing directly to the patient's bedside. The company is developing a rapid, quantitative diagnostic platform that utilizes blood, nasal swab, urine, and saliva tests to deliver results within minutes. Their plug-and-play device is designed to perform panel tests for a variety of diseases, making healthcare more accessible and efficient. Instadiagnostics focuses on providing quick and accurate diagnostic solutions in clinical settings.
Notable figures associated with Instadiagnostics include key industry experts and investors who support their innovative approach to healthcare. The company has achieved significant milestones in developing its diagnostic platform, positioning itself as a leader in the field of rapid, multiplexed point-of-care diagnostics. By reducing the time and complexity involved in obtaining diagnostic results, Instadiagnostics has the potential to significantly impact patient care and streamline clinical workflows.
Companies similar to Instadiagnostics include Prompt Diagnostics, NAT Diagnostics, Test Diagnostics and First Light Diagnostics.
Instadiagnostics was founded in 2015.
Instadiagnostics' headquarters is located in Philadelphia, PA, US.
Instadiagnostics' most recent funding round was for $1M (USD) in August 2021.
As of Aug 31, 2021, Instadiagnostics has disclosed funding of $6.7M (USD). Undisclosed round amounts are excluded.
Instadiagnostics has 7 employees as of Feb 4, 2024.
First Light Diagnostics
firstlightbio.com
